Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

601 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Completed

A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders

NCT02125318

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +21 more
Locations
  • East Valley Hematology and Oncology Medical Group Burbank, California, United States
  • California Cancer Associates for Research & Excellence (cCARE) Encinitas, California, United States
  • California Cancer Associates for Research & Excellence (cCARE) Escondido, California, United States
  • California Cancer Associates For Research and Excellence Fresno, California, United States
View Trial Details
Completed

Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

NCT00786812

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Belo Horizonte, Minas Gerais, Brazil
  • Novartis Investigative Site Curitiba, Paraná, Brazil
  • Novartis Investigative Site Rio de Janeiro, Brazil
  • Novartis Investigative Site Porto Alegre, Rio Grande do Sul, Brazil
View Trial Details
Completed

A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

NCT00481247

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Molecular Md Portland, Oregon, United States
  • Local Institution Buenos Aires, Argentina
  • Local Institution Capital Federal, Buenos Aires, Argentina
  • Local Institution Capital Federal, Buenos Aires, Argentina
View all 109 locations
View Trial Details
Completed

Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment

NCT00072579

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • CCOP - Western Regional, Arizona Phoenix, Arizona, United States
  • CCOP - Bay Area Tumor Institute Oakland, California, United States
  • CCOP - Mount Sinai Medical Center Miami Beach, Florida, United States
  • Regional Radiation Oncology Center at Rome Rome, Georgia, United States
View all 15 locations
View Trial Details

Related conditions